
Tardive Dyskinesia (TD): What It Is, Symptoms & Treatment
What is tardive dyskinesia? Tardive dyskinesia (TD) is a neurological syndrome that involves involuntary (out of your control) movements. Taking antipsychotic (neuroleptic) medications is the main cause of …
Tardive Dyskinesia | National Alliance on Mental Illness (NAMI)
Download PDF What is tardive dyskinesia? Tardive dyskinesia (TD) is a movement disorder that causes a range of repetitive muscle movements in the face, neck, arms, and legs. TD symptoms are beyond …
The earlier the symptoms of tardive dyskinesia are found, the more likely it is that something can be done to prevent the condition from becoming permanent. More on this topic Patient education: Side …
Tardive Dyskinesia, also known as TD, is an involuntary movement disorder that is associated with long term use of antipsychotic medications. This condition is characterized by uncontrollable, abnormal …
- [PDF]
PATIENT FACT SHEET
Tardive dyskinesia is a condition defined by delayed (tardive) involuntary movements of the body (dyskinesia) that often occur after the short- and long-term use of certain medications designed to ...
Tardive Dyskinesia (TD): Definition, Symptoms, Causes, Treatment - WebMD
Nov 6, 2025 · Learn what causes tardive dyskinesia (TD), how symptoms can change, and what treatments and lifestyle steps can help you manage this movement disorder.
Tardive Dyskinesia (TD) is usually caused by long term use of antipsychotic or neuroleptic medications though it may occur as soon as 6 weeks. Persons with neurological or degenerative conditions of the …
TDhelp.org - National Organization for Tardive Dyskinesia
Welcome to the online home of The National Organization for Tardive Dyskinesia (NOTD). This website provides you with a wealth of information about TD, from finding a specialist, receiving the latest TD …
Tardive Dyskinesia (TD) Awareness Toolkit - gapna.org
Antipsychotic medication (AP) is the main treatment option for managing SMIs, both in the acute phase of illness and for longer-term management. APs are effective in controlling SMI symptoms, and …
†Base: TD Patient ATU 2024: Responses based on survey question: “Since first experiencing [CONDITION], how have the following areas of your life been affected, if at all?” Please use a scale …